4//SEC Filing
ZERBE ROBERT L MD 4
Accession 0001140361-24-046456
CIK 0000887359other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:05 PM ET
Size
12.9 KB
Accession
0001140361-24-046456
Insider Transaction Report
Form 4
Vericel CorpVCEL
ZERBE ROBERT L MD
Director
Transactions
- Sale
Common Stock
2024-11-11$55.00/sh−2,500$137,500→ 26,595 total - Sale
Common Stock
2024-11-12$57.50/sh−2,500$143,750→ 26,595 total - Exercise/Conversion
Common Stock
2024-11-12$13.05/sh+2,500$32,625→ 29,095 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-11+2,500→ 15,000 totalExercise: $13.05Exp: 2028-05-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-12+2,500→ 12,500 totalExercise: $13.05Exp: 2028-05-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2024-11-11$13.05/sh+2,500$32,625→ 29,095 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024.
- [F2]These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001220363
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:05 PM ET
- Size
- 12.9 KB